medical condition treated by semaglutide Semaglutide: A New Hope for Sustainable Weight Management Compound Semaglutide

Reducing glucagon levels leads to a decrease in hepatic glucose output, which helps control blood glucose levels

Commonly reported symptoms include: Abdominal bloating Abdominal pain Constipation GERD (Gastroesophageal reflux disease) Heartburn Indigestion Loss of appetite Low blood sugar levels Malnutrition Nausea Regurgitation Upset stomach Vomiting Weight loss Symptoms of gastroparesis may appear as other medical conditions, like GERD, for example

This is especially important now that compound semaglutide is no longer a routine pathway and patients should transition to approved options when clinically appropriate

Monitoring may be appropriate in higher-risk individuals